• Conditions and diseases

  • Blood and immune system •
  • Cancer •
  • Cardiovascular •
  • Central nervous system •
  • Digestive system •
  • Ear and nose •
  • Endocrine, nutritional and metabolic •
  • Eye •
  • Gynaecology, pregnancy and birth •
  • Infectious diseases •
  • Injuries, accidents and wounds •
  • Mental health and behavioural conditions •
  • Mouth and dental •
  • Musculoskeletal •
  • Respiratory •
  • Skin •
  • Urogenital

• Public health

  • Accidents and injuries •
  • Alcohol •
  • Behaviour change •
  • Cancer •
  • Cardiovascular disease •
  • Child health •
  • Child social care •
  • Chronic illness •
  • Diabetes •
  • Drugs •
  • Environmental health •
  • Infectious diseases •
  • Maternal health •
  • Mental health •
  • Non-communicable diseases •
  • Obesity and diet •
  • Occupational health •
  • Older people •
  • Physical activity •
  • Sexual health •
  • Smoking and tobacco •
  • Transport •
  • Vaccine preventable diseases •
  • Working with and involving communities

• Treatments, Procedures and Devices

  • Bones and joint surgery •
  • Cardiovascular surgery •
  • Cardiovascular system drug treatments •
  • Clinical devices •
  • Diagnostic imaging •
  • Diagnostic procedures •
  • Digestive tract and other abdominal organs surgery •
  • Drug treatments •
  • Endocrine system and breast surgery •
  • Eye surgery •
  • Nervous system surgery •
  • Radiotherapy •
  • Screening •
  • Surgical procedures •
  • Therapeutic procedures •
  • Tissue and organ donation •
  • Urogenital surgery

• Guidance by type

  • Clinical Guidelines •
  • Technology appraisals •
  • Public health guidance •
  • Diagnostics guidance •
  • Interventional procedures guidance •
  • Medical technologies guidance •
  • Cancer service guidance •
  • Quality standards

• Guidance by date

  • View the guidance by date published

About NICE guidance Close

Navigation

• NICE guidance

• Find guidance
• NICE Pathways
• Latest guidance
• Guidance by type
• Guidance in development
• How guidance is produced
• NICE guidance research recommendations
• Guidance for patients and public
• Other publications
• Patient safety solutions pilot
• Quality standards

The VeriQ system for assessing graft flow during coronary artery bypass graft surgery

NICE are investigating the claim: The VeriQ system offers enhanced utility as a non-invasive method in assessing the patency of grafts carried out during coronary artery bypass surgery. The technology uses intra-operative transit time flow measurements (TTFM) to quality assure graft patency.

For more information please see the evaluation scope below.

Status:	History
Expected date of issue:	November 2011
Notification date:	November 2010
Topic area: Cardiovascular Surgical procedures

Project team | Schedule | Stakeholders | Project history | Key documents

 

NICE project team

Patient Involvement Lead:	Laura Norburn
Analyst:	Mukesh Dhariwal
Communications Lead:	Tonya Gillis
Project manager:	Marlon Hope
Implementation Lead:	Katie Worrall

Top

 

Provisional schedule

Submission Date Text:	TBC
Topic Selection:	01 December 2010
Draft guidance meeting	16 June 2011
Consultation opens:	07 July 2011
Consultation ends:	30 August 2011
Final guidance meeting:	15 September 2011

Top

 

Stakeholders

To be confirmed

Top

 

Project history

Date Update 5 August 2011 The National Institute for Health and Clinical Excellence (NICE) is evaluating this technology

Top

 

Key documents

The VeriQ system for assessing graft flow during coronary artery bypass graft surgery: equality impact assessment 16 November 2011 VeriQ: medical technologies consultation 08 July 2011 Press release: NICE consults on device to improve the outcome of heart bypass graft surgery 08 July 2011

This page was last updated: 15 November 2011